[Detection of rupture of fetal membranes using a commercially available fibronectin test kit].
In a clinical examination an attempt was made to confirm the aptitude of a commercially available immunoassay to detect amniotic fluid. Pure amniotic fluid gained by amniocentesis, not mixed with other secretions, was used. On examination using three different batches the sensitivity of this test amounted to 35/55 in all, or 64%. We came to the conclusion that the present test was not sufficiently reliable to prove or disprove the discharge of amniotic fluid. An explanation is needed especially regarding the role played by the forces which occur during contractions and the presence of cervical and vaginal secretions when fetal fibronectin is found to be present. The evidence of fetal fibronectin could possibly become more important as a predictor of imminent labour than as being proof of the admixture of amniotic fluid in cervical and vaginal secretions.
Reus
W A
WA
Abteilung für Geburtsmedizin, Universitäts-Frauenklinik, Klinikum Rudolf Virchow (Charlottenburg), Freien Universität Berlin.
Hofstaetter
C
C
Mährlein
A
A
Dudenhausen
J W
JW
D000653:Amniotic Fluid / Q000737:chemistry*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000175:diagnosis*; D005353:Fibronectins / Q000032:analysis*; D006801:Humans; D007231:Infant, Newborn; D011237:Predictive Value of Tests; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011933:Reagent Kits, Diagnostic
D005353:Fibronectins; D011933:Reagent Kits, Diagnostic
Zum Nachweis des Blasensprungs mit Hilfe eines kommerziell erhältlichen Fibronectin-Nachweistests.